Antibiotic-Free future: study tests stopping trachoma treatment
NCT ID NCT04185402
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether it is safe to stop giving annual azithromycin to communities with low levels of trachoma, an eye infection that can cause blindness. Over 3,900 people in Niger took part. Researchers compared stopping treatment after at least 5 years versus continuing for 3 more years to see if the infection would stay under control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRACHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Programme National de Santé Oculaire (PNSO)
Niamey, Niger
More trials for these conditions
Other studies related to the condition(s) this trial covers.